Aillis, Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO: Sho Okiyama) launched 'Evidence Finder,' an AI-based evidence search function for physicians, on May 19, 2026.
'Evidence Finder' is designed to prioritize the transparency of citations and mitigate AI hallucinations. In response to a physician's query, the system integrates PubMed literature searches with AI answer generation, presenting results with clearly marked references. It features a standard 'Verify' function that automatically confirms the existence of cited papers, providing a streamlined path for doctors to reach primary sources as quickly as possible.
Under the mission 'Building an open healthcare environment through co-creation,' Aillis developed this tool to address the challenge of efficiently accessing the latest medical evidence. While the service is not classified as a medical device and is intended for general medical information purposes only, the company plans to release additional features continuously based on professional feedback.
### About Aillis, Inc. Founded in November 2017, Aillis is a healthcare AI startup led by CEO Okiyama, an active physician. The company consists of professionals from diverse backgrounds, including healthcare, government administration (Ministry of Health, Labour and Welfare, etc.), and data science. They specialize in developing AI medical devices that digitize expert clinical skills using machine learning technologies.
FACT BOX
- Source: PR TIMES
- Category: New Product
- Products / services: Evidence Finder